Farmak has expanded its portfolio with a new product, Panjest® Lactase. The dietary supplement is recommended for consumption with lactose-containing foods as an additional source of enzymes for people who have difficulty digesting lactose.
Difficulty digesting lactose is common worldwide. According to NIDDK*, approximately 68% of the world’s population has lactose malabsorption — a reduced ability to digest lactose after infancy.
Panjest® Lactase contains the enzyme lactase, which improves lactose digestion in people who have difficulty digesting lactose. The product may be recommended by a healthcare professional as part of the daily diet for people who have difficulty digesting lactose, as an additional source of non-animal-derived enzymes to be consumed with lactose-containing foods.
The dietary supplement is available in capsule form.
The launch of Panjest® Lactase further expands the Panjest range and strengthens Farmak’s portfolio in the dietary supplement category.
Farmak currently has a portfolio of more than 450 products and supplies medicines to 60 countries worldwide.
Advertisement for a dietary supplement. Not a medicinal product.
Manufacturer: AORA HEALTH, S.L., CL. De Faraday Nº 7, Parque Cientifico de Madrid, 28049 Madrid, Spain, for Farmak JSC, Ukraine. Name and address of the market operator (for consumer complaints): Farmak JSC, 63 Kyrylivska St., Kyiv, 04080, Ukraine. Tel.: +38 (044) 239 19 40. www.farmak.ua
UKR/PROMO/08/2026/DD/PNT_L/PPR/001
*NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) data. https://www.niddk.nih.gov/health-information/digestive-diseases/lactose-intolerance/definition-facts
